Effect of three herbal extracts on cytochrome P450 and possibility of interaction with drugs

Journal of the Food Hygienic Society of Japan

Volumn 54, Issue 1, 2013, Pages 56-64

  Yokotani, Kaori ^a,b   Chiba, Tsuyoshi ^a   Sato, Yoko ^a   Nakanishi, Tomoko ^a   Murata, Masatsune ^b   Umegaxj, Keizo ^a  

^a NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^b OCHANOMIZU UNIVERSITY   (Japan)

Author keywords

Black cohosh; Hepatic cytochrome P450; Herb drug interaction; Herbal extract; Salacia; Valerian

Indexed keywords

CYTOCHROME P450; PLANT EXTRACT; VALERIAN;

ACTAEA; ANIMAL; ARTICLE; CELL CULTURE; DRUG INTERACTION; ENZYMOLOGY; FEMALE; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; LIVER MICROSOME; MALE; METABOLISM; MOUSE; SALACIA;

ANIMALS; CELLS, CULTURED; CIMICIFUGA; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; FEMALE; LIVER; MALE; MICE; MICE, INBRED ICR; MICROSOMES, LIVER; PLANT EXTRACTS; SALACIA; VALERIAN;

CIMICIFUGA DAHURICA; MUS; VALERIANA;

EID: 84875754830     PISSN: 00156426     EISSN: None     Source Type: Journal    
DOI: 10.3358/shokueishi.54.56     Document Type: Article

References (37)

1. Gershwin, M. E, Borchers, A. T., Keen, C. L., Hendler, S., Hagie, F., Greenwood, M. R. Public safety and dietary supplementation. Ann. N.Y. Acad. Sci., 1190, 104- 117 (2010).
2. van Breemen, R. B., Fong, H. H., Farnsworth, N. R. Ensuring the safety of botanical dietary supplements. Am. J. Clin. Nutr., 87, 509S-513S (2008).
3. Larrey, D. Hepatotoxicity of herbal remedies. J. Hepatol., 26 (Suppl. 1), 47-51 (1997).
4. Sleath, B., Rubin, R. H., Campbell, W., Gwyther, L., Clark, T. Ethnicity and physician-older patient communication about alternative therapies. J. Altera. Complement Med., 7, 329-335 (2001).
5. Tanaka, E. Clinically important pharmacokinetic drug- drug interactions: role of cytochrome P450 enzymes. J. Clin. Pharm. Ther., 23, 403-416 (1998).
6. Tirona, R. G., Bailey, D. G. Herbal product-drug interactions mediated by induction. Br. J. Clin. Pharmacol., 61, 677-681 (2006).
7. Bent, S., Ko, R. Commonly used herbal medicines in the United States: a review. Am. J. Med., 116, 478-485 (2004).
8. Cantoni, L., Rozio, M., Mangolini, A., Hauri, L., Caccia, S. Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse. Toxicol. Sci., 75, 25-30 (2003).
9. Ulbricht, C., Chao, W., Costa, D., Rusie-Seamon, E., Weissner, W., Woods, J. Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration. Curr. Drug Metab., 9, 1063-1120 (2008).
10. Sugiyama, T., Kubota, Y., Shinozuka, K., Yamada, S., Wu, J., Umegaki, K. Ginkgo biloba extract modifies hypoglycemic action of tolbutamide via hepatic cytochrome P450 mediated mechanism in aged rats. Life Sci., 75, 1113-1122 (2004).
11. Kubota, Y., Kobayashi, K., Tanaka, N., Nakamura, K, Kunitomo, M., Umegaki, K., Shinozuka, K. Interaction of Ginkgo biloba extract (GBE) with hypotensive agent, nicardipine, in rats. In Vivo, 17, 409-412 (2003).
12. Kubota, Y., Kobayashi, K., Tanaka, N., Nakamura, K., Kunitomo, M., Umegaki, K., Shinozuka, K. Pretreatment with Ginkgo biloba extract weakens the hypnosis action of phenobarbital and its plasma concentration in rats. J. Pharm. Pharmacol., 56, 401-405 (2004).
13. Taki, Y., Yokotani, K, Yamada, S., Shinozuka, K., Kubota, Y., Watanabe, Y., Umegaki, K Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome P450 enzymes by bilobalide in mice. Phytomedicine, 19, 177-182 (2012).
14. Yokotani, K, Chiba, T., Sato, Y., Taki, Y., Yamada, S., Shinozuka, K., Murata, M., Umegaki, K. Hepatic cytochrome P450 mediates interaction between warfarin and Coleus forskohlii extract in vivo and in vitro. J. Pharm. Pharmacol., 64, 1793-1801 (2012).
15. Reagan-Shaw, S., Nihal, M., Ahmad, N. Dose translation from animal to human studies revisited. FASEB J., 22, 659-661 (2008).
16. Umegaki, K, Saito, K, Kubota, Y., Sanada, H., Yamada, K., Shinozuka, K. Ginkgo biloba extract markedly induces pentoxyresorufin Odealkylase activity in rats. Jpn. J. Pharmacol., 90, 345-351 (2002).
17. Habig, W. H., Jakoby, W. B. Assays for differentiation of glutathione S-transferases. Methods Enzymol., 77, 398- 405 (1981).
18. Joy, D., Joy, J., Duane, P. Black cohosh: a cause of abnormal postmenopausal liver function tests. Climacteric, 11, 84-88 (2008).
19. Vitetta, L., Thomsen, M., Sali, A. Black cohosh and other herbal remedies associated with acute hepatitis. Med. J. Aust., 178, 411-412 (2003).
20. Zimmermann, R., Witte, A., Voll, R. E., Strobel, J., Frieser, M. Coagulation activation and fluid retention associated with the use of black cohosh: a case study. Climacteric, 13, 187-191 (2010).
21. Lefebvre, T., Foster, B. C., Drouin, C. E., Krantis, A., Livesey, J. F., Jordan, S. A. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. J. Pharm. Sci., 7, 265-273 (2004).
22. Budzinski, J. W., Foster, B. C., Vandenhoek, S., Arnason, J. T. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine, 7, 273-282 (2000).
23. Pang, X., Cheng, J., Krausz, K. W., Guo, D. A., Gonzalez, F. J. Pregnane X receptor-mediated induction of Cyp3a by black cohosh. Xenobiotica, 41, 112-123 (2011).
24. Tsukamoto, S., Aburatani, M., Ohta, T. Isolation of CYP3A4 inhibitors from the black cohosh (Cimicifuga racemosa). Evid. Based Complement Alternat. Med., 2, 223-226 (2005).
25. Huang, Y., Jiang, B., Nuntanakorn, P., Kennelly, E. J., Shord, S., Lawal, T. O., Mahady, G. B. Fukinolic acid derivatives and triterpene glycosides from black cohosh inhibit CYP isozymes, but are not cytotoxic to Hep-G2 cells in vitro. Curr. Drug Saf., 5, 118-124 (2010).
26. Waxman, D. J., Holloway, M. G. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol. Pharmacol., 76, 215-228 (2009).
27. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., Guengerich, F. P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther., 270, 414-423 (1994).
28. Wienkers, L. C., Heath, T. G. Predicting in vivo drug interactions from in vitro drug discovery data. Nat. Rev. Drug Discov., 4, 825-833 (2005).
29. (Solatia reticulata) 46, 527-540 (2001).
30. Leakey, J. E., Cunny, H. C., Bazare, J., Jr., Webb, P. J., Feuers, R. J., Duffy, P. H., Hart, R. W. Effects of aging and caloric restriction on hepatic drug metabolizing enzymes in the Fischer 344 rat. I: The cytochrome P-450 dependent monooxygenase system. Mech. Ageing Dev., 48, 145-155 (1989).
31. Hashmi, R. S., Siddiqui, A. M., Kachole, M. S., Pawar, S. S. Alterations in hepatic microsomal mixed-function oxidase system during different levels of food restriction in adult male and female rats. J. Nutr., 116, 682-688 (1986).
32. Wuttke, W., Gorkow, C., Seidlova-Wuttke, D. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in post- menopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study. Menopause, 13, 185-196 (2006).
33. Tchaikovski, S. N., Rosing, J. Mechanisms of estrogen- induced venous thromboembolism. Thromb. Res., 126, 5-11 (2010).
34. Mishell, D. R., Jr. Oral contraception: past, present, and future perspectives. Int. J. Fertil., 36 (Suppl. 1), 7-18 (1991).
35. Vehkavaara, S., Silveira, A., Hakala-Ala-Pietila, T., Virkamaki, A., Hovatta, O., Hamsten, A., Taskinen, M. R., Yki-Jarvinen, H. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb. Haemost., 85, 619-625 (2001).
36. Cosman, F., Baz-Hecht, M., Cushman, M., Vardy, M. D., Cruz, J. D., Nieves, J. W., Zion, M., Lindsay, R. Short- term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature. Thromb. Res., 116, 1-13 (2005).
37. Teschke, R., Bahre, R., Genthner, A., Fuchs, J., Schmidt-Taenzer, W., Wolff, A. Suspected black cohosh hepatotoxicity-challenges and pitfalls of causality assessment. Maturitas, 63, 302-314 (2009).